Mark J. Ratain to Adaptor Proteins, Signal Transducing
This is a "connection" page, showing publications Mark J. Ratain has written about Adaptor Proteins, Signal Transducing.
Connection Strength
0.071
-
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies. Clin Cancer Res. 2009 Feb 15; 15(4):1428-34.
Score: 0.071